Salvatore Salamone

Salamone earned two bachelor's degrees from Villanova University, a master's and a PhD degree from Rutgers University and was a Science Engineering Research Council (SERC) Post-Doctoral Fellow at the University of Oxford, UK.^[1]

Salamore is responsible for the development of many of the major reagents used within psychiatric drug level monitoring.^[2][3] He is the founder of Saladax Biomedical, Inc.^[1] His contributions to diagnostic medicine have been recognized through several local awards, including the Ben Franklin Innovation Award^[4] and the New Jersey Inventors Hall of Fame in 2016.^[5] Salamone has 70 FDA-approved products and more than 200 instrument applications. ^{[citation needed]} He is the editor of a textbook on benzodiazapines^[6] and is also the holder of 41 issued US patents.^[7] The International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) awarded Salamone the C.E. Pippenger Award for outstanding contributions to the field of Therapeutic Drug Monitoring in 2021.^[8]